Download Files:
Ensartinib
SKU
HY-103714-Get quote
Category Reference compound
Tags Anaplastic lymphoma kinase (ALK);c-Met/HGFR, Cancer, Protein Tyrosine Kinase/RTK
Products Details
Product Description
– Ensartinib (X-396) is a potent and dual ALK/MET inhibitor with IC50s of <0.4 nM and 0.74 nM, respectively.
Web ID
– HY-103714
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C26H27Cl2FN6O3
Citations
– Cancers. 2020 Mar 28;12(4):813.|Drug Des Dev Ther. 2020 Nov 30;14:5259-5273.
References
– [1]Lovly CM, et al. Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinaseinhibitors. Cancer Res. 2011 Jul 15;71(14):4920-31.
CAS Number
– 1370651-20-9
Molecular Weight
– 561.44
SMILES
– O=C(C1=NN=C(N)C(O[C@@H](C2=C(Cl)C=CC(F)=C2Cl)C)=C1)NC3=CC=C(C(N4C[C@@H](C)N[C@@H](C)C4)=O)C=C3
Clinical Information
– Launched
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Anaplastic lymphoma kinase (ALK);c-Met/HGFR
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.